Dhampur Bio Organics Limited has informed the Exchange about Copy of Newspaper Publication
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics has published its audited Q4 and full-year FY25 results in Business Standard (English and Hindi). For Q4 FY25, consolidated total income rose to ₹703.80 crore (vs ₹599.66 crore in Q4 FY24) and net profit after tax grew to ₹44.80 crore (vs ₹39.41 crore). However, full-year FY25 net profit dropped sharply to ₹14.69 crore (vs ₹46.49 crore in FY24), and EPS fell to ₹2.21 from ₹7.00. The Board has recommended a final dividend of ₹1.25 per share (12.5%) amounting to ₹8.30 crore. Sugar being a seasonal industry, the company notes quarterly performance may not reflect annual trends.
The sharp decline in full-year profit despite higher revenues suggests margin pressure, which is a negative signal for shareholders. However, the strong Q4 recovery and maintained dividend may provide some support. Investors should watch for explanations on the annual profit decline.